These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30226948)

  • 1. Clinical evaluation of 3-day tebipenem pivoxil therapy in children with community-acquired pneumonia.
    Sakata H
    Jpn J Antibiot; 2016 Sep; 69(3):125-130. PubMed ID: 30226948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric community-acquired pneumonia treated with a three-day course of tebipenem pivoxil.
    Sakata H; Kuroki H; Ouchi K; Tajima T; Iwata S;
    J Infect Chemother; 2017 May; 23(5):307-311. PubMed ID: 28238680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of tebipenem pivoxil treatment in children with pneumonia, who had no relief despite having administered oral beta-lactam antibiotics].
    Sakata H
    Jpn J Antibiot; 2011 Jun; 64(3):171-7. PubMed ID: 21861308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of pneumonia-causing pathogenic organisms in children and the usefulness of tebipenem pivoxil for their treatment.
    Kuroki H; Tateno N; Ikeda H; Saito N
    J Infect Chemother; 2010 Aug; 16(4):280-7. PubMed ID: 20352278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of tebipenem pivoxil (ME1211), a novel oral carbapenem antibiotic, in pediatric patients with otolaryngological infection or pneumonia.
    Sato N; Kijima K; Koresawa T; Mitomi N; Morita J; Suzuki H; Hayashi H; Shibasaki S; Kurosawa T; Totsuka K
    Drug Metab Pharmacokinet; 2008; 23(6):434-46. PubMed ID: 19122338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of safety and efficacy of tebipenem pivoxil granules for pediatric in pneumonia, otitis media and sinusitis].
    Kataoka H; Kasahara H; Sasagawa Y; Matsumoto M; Shimada S
    Jpn J Antibiot; 2016 Feb; 69(1):53-76. PubMed ID: 27290830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of tebipenem pivoxil, a novel oral carbapenem antibiotic, in experimental animals].
    Kijima K; Morita J; Suzuki K; Aoki M; Kato K; Hayashi H; Shibasaki S; Kurosawa T
    Jpn J Antibiot; 2009 Jun; 62(3):214-40. PubMed ID: 19882982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefetamet pivoxil in community-acquired pneumonia: an overview.
    Kissling M
    Curr Med Res Opin; 1992; 12(10):631-9. PubMed ID: 1633721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of new oral antimicrobial agents in outpatient treatment of pneumonia in children].
    Ouchi K; Sunakawa K
    Jpn J Antibiot; 2014 Jun; 67(3):157-66. PubMed ID: 25163249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections].
    Baba S; Yamanaka N; Suzuki K; Furukawa M; Furuya N; Ubukata K; Totsuka K
    Jpn J Antibiot; 2009 Apr; 62(2):155-77. PubMed ID: 19673357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of diet on the pharmacokinetics of tebipenem pivoxil fine granules in healthy male volunteers].
    Nakashima M; Morita J; Takata T; Aizawa K
    Jpn J Antibiot; 2009 Apr; 62(2):136-42. PubMed ID: 19673355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good transfer of tebipenem into middle ear effusion conduces to the favorable clinical outcomes of tebipenem pivoxil in pediatric patients with acute otitis media.
    Sugita R
    J Infect Chemother; 2013 Jun; 19(3):465-71. PubMed ID: 23393013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of administration times and clinical efficacy of carbapenems in the treatment of moderate community-acquired bacterial pneumonia].
    Okimoto N; Yamato K; Kurihara T; Honda Y; Osaki K; Asaoka N; Fujita K; Ohba H
    Nihon Kokyuki Gakkai Zasshi; 2004 Oct; 42(10):871-4. PubMed ID: 15565999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tissue and aural discharge distribution of tebipenem pivoxil].
    Baba S; Kasahara H; Morita J; Aizawa K; Sunakawa K
    Jpn J Antibiot; 2009 Apr; 62(2):127-35. PubMed ID: 19673354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and bacteriological evaluation of ceftriaxone (CTRX) dosed once daily in children with community-acquired pneumonia].
    Toyonaga Y; Kanemura H; Kitano M; Mitsui Y; Ishihara T; Hoshiai M; Ohno R
    Jpn J Antibiot; 1999 Apr; 52(4):322-32. PubMed ID: 10396689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
    Lee PI; Wu MH; Huang LM; Chen JM; Lee CY
    J Microbiol Immunol Infect; 2008 Feb; 41(1):54-61. PubMed ID: 18327427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-acquired pneumonia in children.
    Stuckey-Schrock K; Hayes BL; George CM
    Am Fam Physician; 2012 Oct; 86(7):661-7. PubMed ID: 23062094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal absorption mechanism of tebipenem pivoxil, a novel oral carbapenem: involvement of human OATP family in apical membrane transport.
    Kato K; Shirasaka Y; Kuraoka E; Kikuchi A; Iguchi M; Suzuki H; Shibasaki S; Kurosawa T; Tamai I
    Mol Pharm; 2010 Oct; 7(5):1747-56. PubMed ID: 20735088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.